These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 29333729)

  • 1. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
    Xie YQ; Wei L; Tang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering vaccines and niches for immune modulation.
    Purwada A; Roy K; Singh A
    Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery-free injectable macroscale biomaterials for local cancer immunotherapy.
    Lei K; Tang L
    Biomater Sci; 2019 Feb; 7(3):733-749. PubMed ID: 30637428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanical Immunoengineering of T cells for Therapeutic Applications.
    Lei K; Kurum A; Tang L
    Acc Chem Res; 2020 Dec; 53(12):2777-2790. PubMed ID: 33258577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the clinical impact of biomaterials in cancer immunotherapy.
    Gammon JM; Dold NM; Jewell CM
    Oncotarget; 2016 Mar; 7(13):15421-43. PubMed ID: 26871948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in engineering local drug delivery systems for cancer immunotherapy.
    Abdou P; Wang Z; Chen Q; Chan A; Zhou DR; Gunadhi V; Gu Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1632. PubMed ID: 32255276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immunotherapy: accomplishments to date and future promise.
    Helmy KY; Patel SA; Nahas GR; Rameshwar P
    Ther Deliv; 2013 Oct; 4(10):1307-20. PubMed ID: 24116914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
    Yang J; Zhang C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoengineering the next generation of arthritis therapies.
    Klimak M; Nims RJ; Pferdehirt L; Collins KH; Harasymowicz NS; Oswald SJ; Setton LA; Guilak F
    Acta Biomater; 2021 Oct; 133():74-86. PubMed ID: 33823324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.
    Wang C; Ye Y; Hu Q; Bellotti A; Gu Z
    Adv Mater; 2017 Aug; 29(29):. PubMed ID: 28556553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interfacing Biomaterials with Synthetic T Cell Immunity.
    Su FY; Mac QD; Sivakumar A; Kwong GA
    Adv Healthc Mater; 2021 Aug; 10(15):e2100157. PubMed ID: 33887123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivering safer immunotherapies for cancer.
    Milling L; Zhang Y; Irvine DJ
    Adv Drug Deliv Rev; 2017 May; 114():79-101. PubMed ID: 28545888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Biomaterials with Intrinsic Immunomodulation Effects for Cancer Immunotherapy.
    Chen W; Li C; Jiang X
    Small Methods; 2023 May; 7(5):e2201404. PubMed ID: 36811240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomaterial Strategies for Immunomodulation.
    Hotaling NA; Tang L; Irvine DJ; Babensee JE
    Annu Rev Biomed Eng; 2015; 17():317-49. PubMed ID: 26421896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in Engineering Cells for Cancer Immunotherapy.
    Xu X; Li T; Shen S; Wang J; Abdou P; Gu Z; Mo R
    Theranostics; 2019; 9(25):7889-7905. PubMed ID: 31695806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic synthetic and natural materials for immunoengineering.
    Slezak A; Chang K; Hossainy S; Mansurov A; Rowan SJ; Hubbell JA; Guler MO
    Chem Soc Rev; 2024 Feb; 53(4):1789-1822. PubMed ID: 38170619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomaterial-Based Implantable Devices for Cancer Therapy.
    Chew SA; Danti S
    Adv Healthc Mater; 2017 Jan; 6(2):. PubMed ID: 27886461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local delivery of checkpoints antibodies.
    Wang C; Ye Y; Gu Z
    Hum Vaccin Immunother; 2017 Jan; 13(1):245-248. PubMed ID: 27668759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy.
    Lee D; Huntoon K; Wang Y; Jiang W; Kim BYS
    Adv Mater; 2021 Jul; 33(27):e2007576. PubMed ID: 34050699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.